Literature DB >> 14969068

Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention.

M A Quinn1, P Emery.   

Abstract

Therapeutic strategies for the treatment of rheumatoid arthritis (RA) have changed significantly in the last decade. The emphasis is now on early intervention with the aim of preventing disability and irreversible damage. Advocates of early intervention would suggest an alteration in the disease process, not just debulking of inflammatory disease. The data would at least support attenuation of the disease process with aggressive early therapy. Further research is required to elucidate the scientific mechanisms involved and their impact on the pathological progress of RA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14969068

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  57 in total

1.  Sonography and subclinical synovitis.

Authors:  B Bresnihan; D Kane
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

Review 2.  [Early diagnosis of chronic systemic inflammatory disorders].

Authors:  B Hellmich; F Merkel; M Weber; W L Gross
Journal:  Internist (Berl)       Date:  2005-04       Impact factor: 0.743

Review 3.  Treatment of rheumatoid arthritis.

Authors:  Paul Emery
Journal:  BMJ       Date:  2006-01-21

Review 4.  [Macrophage specific MRI imaging for antigen induced arthritides. A potential new strategy for the diagnosis of rheumatoid arthritis].

Authors:  G H Simon; H E Daldrup-Link; E J Rummeny
Journal:  Radiologe       Date:  2007-01       Impact factor: 0.635

5.  Idiopathic inflammatory myopathy: treatment options.

Authors:  Stephen J DiMartino
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

6.  Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.

Authors:  Clare Oni; Sheryl Mitchell; Katherine James; Wan-Fai Ng; Bridget Griffiths; Victoria Hindmarsh; Elizabeth Price; Colin T Pease; Paul Emery; Peter Lanyon; Adrian Jones; Michele Bombardieri; Nurhan Sutcliffe; Costantino Pitzalis; John Hunter; Monica Gupta; John McLaren; Annie Cooper; Marian Regan; Ian Giles; David Isenberg; Vadivelu Saravanan; David Coady; Bhaskar Dasgupta; Neil McHugh; Steven Young-Min; Robert Moots; Nagui Gendi; Mohammed Akil; Francesca Barone; Ben Fisher; Saaeha Rauz; Andrea Richards; Simon J Bowman
Journal:  Rheumatology (Oxford)       Date:  2015-10-27       Impact factor: 7.580

Review 7.  Remission-induction therapies for early rheumatoid arthritis: evidence to date and clinical implications.

Authors:  Francisco Espinoza; Sylvie Fabre; Yves-Marie Pers
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-06-13       Impact factor: 5.346

8.  Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.

Authors:  Carol A Wallace; Edward H Giannini; Steven J Spalding; Philip J Hashkes; Kathleen M O'Neil; Andrew S Zeft; Ilona S Szer; Sarah Ringold; Hermine I Brunner; Laura E Schanberg; Robert P Sundel; Diana Milojevic; Marilynn G Punaro; Peter Chira; Beth S Gottlieb; Gloria C Higgins; Norman T Ilowite; Yukiko Kimura; Stephanie Hamilton; Anne Johnson; Bin Huang; Daniel J Lovell
Journal:  Arthritis Rheum       Date:  2011-12-19

Review 9.  Role of ultrasonography in diagnosing early rheumatoid arthritis and remission of rheumatoid arthritis--a systematic review of the literature.

Authors:  David F Ten Cate; Jolanda J Luime; Nanno Swen; Andreas H Gerards; Mike H De Jager; Natalja M Basoski; Johanna M W Hazes; Cees J Haagsma; Johannes W G Jacobs
Journal:  Arthritis Res Ther       Date:  2013-01-08       Impact factor: 5.156

10.  Long-term clinical, functional, and cost outcomes for early rheumatoid arthritis patients who did or did not achieve early remission in a real-world treat-to-target strategy.

Authors:  Peter M Ten Klooster; Martijn A H Oude Voshaar; Walid Fakhouri; Inmaculada de la Torre; Claudia Nicolay; Mart A F J van de Laar
Journal:  Clin Rheumatol       Date:  2019-06-03       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.